{
    "clinical_study": {
        "@rank": "6549", 
        "acronym": "PEDWAY", 
        "arm_group": {
            "arm_group_label": "Walking Intervention", 
            "arm_group_type": "Experimental", 
            "description": "Pedometer Walking Program"
        }, 
        "brief_summary": {
            "textblock": "This pilot study will assess whether a supported pedometer-based walking program is helpful\n      in maintaining physical activity for breast and head-and-neck cancer patients who are\n      undergoing radiation therapy. Follow-up monitoring sessions will be scheduled to help\n      provide support for physical activity during radiation therapy. We will also examine the\n      relationship of physical activity and quality of life outcomes to help inform future\n      research."
        }, 
        "brief_title": "Feasibility of a Walking Program for Cancer Survivors Receiving Radiation Therapy", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Physical Activity", 
        "condition_browse": {
            "mesh_term": "Head and Neck Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Will the integration of a patient-centered exercise prescription and supportive counseling\n      attenuate declines in physical activity during radiation therapy? To address this question,\n      this study will assess the feasibility of a patient-centered walking program for breast and\n      head-and-neck cancer patients undergoing radiation therapy. Follow-up monitoring sessions\n      will be scheduled to help provide support and ongoing counseling to facilitate increased\n      activity (through walking) during radiation therapy. We will also examine the effect of the\n      walking program on other outcomes such as happiness, depression and sleep to determine point\n      estimates and measures of variability to inform future research."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Survivors with a diagnosis of breast cancer or head and neck cancer\n\n          -  Adults aged 18 years or older\n\n          -  Commencing adjuvant radiation therapy treatments\n\n          -  Karnofsky Performance Status greater than or equal to 60%\n\n        Exclusion Criteria:\n\n          -  Clinical or radiological evidence of active disease, either local or metastatic\n\n          -  Serious non-malignant disease, such as cardiac failure or advanced arthritis of\n             weight bearing joints, which would preclude daily treatment and follow-up\n\n          -  Patients for whom physical activity or exercise is contraindicated\n\n          -  Psychiatric or addictive disorders which preclude obtaining informed consent or\n             adherence to the protocol\n\n          -  Unable to comply with the protocol, measurement and follow-up schedule (e.g.,\n             scheduling conflicts, time commitment)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01886703", 
            "org_study_id": "ACREC 26059"
        }, 
        "intervention": {
            "arm_group_label": "Walking Intervention", 
            "description": "All subjects will be prescribed a low-intensity walking program based on their current activity level and an daily assigned step count goal (with the current physical activity recommendations of 30 minutes of moderate-to-vigorous activity per day or 150 minutes per week as the ideal goal). Participants will be provided with face-to-face counseling and written material describing their specific individualized walking program. Participants will also be instructed to maintain their normal activities as much as possible during the intervention period. Participants will be given a pedometer and instructed to wear it at least 5 days per week for the duration of the study.", 
            "intervention_name": "Pedometer Walking Program", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Physical activity", 
            "Exercise", 
            "Quality of Life", 
            "Radiation Therapy", 
            "Breast Cancer", 
            "Head and Neck Cancer"
        ], 
        "lastchanged_date": "January 10, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Edmonton", 
                    "country": "Canada", 
                    "state": "Alberta", 
                    "zip": "T6J4P9"
                }, 
                "name": "Cross Cancer Institute"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "1", 
        "official_title": "Feasibility of a Supported Walking Program for Breast and Head-and-Neck Cancer Survivors Receiving Adjuvant Radiation Therapy", 
        "other_outcome": [
            {
                "description": "The six-minute walk test (6MWT) measures the distance an individual is able to walk over a six minutes time period on a hard, flat surface (e.g., 100 foot hallway).", 
                "measure": "6-Minute Walk Test", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to anticipated end of radiation therapy of 6 weeks"
            }, 
            {
                "description": "An accelerometer armband will be used to provide a breakdown of an individual's daily activity.", 
                "measure": "Physical Activity", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to anticipated duration of radiation therapy of 6 weeks"
            }, 
            {
                "description": "Rosenberg Self-Esteem Scale (10 item)", 
                "measure": "Self-esteem", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to anticipated duration of radiation therapy of 6 weeks"
            }, 
            {
                "description": "Beck Depression Inventory II (21 item)", 
                "measure": "Depression", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to anticipated duration of radiation therapy of 6 weeks"
            }, 
            {
                "description": "Oxford Happiness Questionnaire (29 items)", 
                "measure": "Happiness", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to anticipated duration of radiation therapy of 6 weeks"
            }, 
            {
                "description": "Pittsburgh Sleep Quality Index (9 item)", 
                "measure": "Sleep", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to anticipated duration of radiation therapy of 6 weeks"
            }, 
            {
                "description": "Visual analogue scale, recorded as part of daily diary", 
                "measure": "Fatigue", 
                "safety_issue": "No", 
                "time_frame": "Recorded daily during study period of 6 weeks"
            }
        ], 
        "overall_official": {
            "affiliation": "University of Alberta and Cross Cancer Institute", 
            "last_name": "Margaret McNeely, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Accrual:  Number of participants agreeing to participate divided by the number of eligible participants Completion rate:  number of participants completing the trial", 
            "measure": "Accrual Rate and Completion Rate", 
            "safety_issue": "No", 
            "time_frame": "Anticipated duration of radiation therapy of 6 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01886703"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Alberta", 
            "investigator_full_name": "Margie McNeely", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Adherence to the intervention protocol:  number of days meeting target step count", 
            "measure": "Adherence", 
            "safety_issue": "No", 
            "time_frame": "Anticipated duration of radiation therapy of 6 weeks"
        }, 
        "source": "University of Alberta", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Alberta", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}